View in EDS

Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance.

Saved in:
Bibliographic Details
Title: Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance.
Authors: Strizki JM; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Gaspar JM; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Howe JA; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Hutchins B; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Mohri H; Aaron Diamond AIDS Research Center, Columbia University Medical Center , New York, New York, USA., Nair MS; Aaron Diamond AIDS Research Center, Columbia University Medical Center , New York, New York, USA., Kinek KC; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., McKenna P; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Goh SL; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Murgolo N; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jan 10; Vol. 68 (1), pp. e0095323. Date of Electronic Publication: 2023 Dec 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38047645
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Strizki+JM%22">Strizki JM</searchLink>; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Gaspar+JM%22">Gaspar JM</searchLink>; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Howe+JA%22">Howe JA</searchLink>; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Hutchins+B%22">Hutchins B</searchLink>; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Mohri+H%22">Mohri H</searchLink>; Aaron Diamond AIDS Research Center, Columbia University Medical Center , New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Nair+MS%22">Nair MS</searchLink>; Aaron Diamond AIDS Research Center, Columbia University Medical Center , New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kinek+KC%22">Kinek KC</searchLink>; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22McKenna+P%22">McKenna P</searchLink>; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Goh+SL%22">Goh SL</searchLink>; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Murgolo+N%22">Murgolo N</searchLink>; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220315061%22">Antimicrobial agents and chemotherapy</searchLink> [Antimicrob Agents Chemother] 2024 Jan 10; Vol. 68 (1), pp. e0095323. <i>Date of Electronic Publication: </i>2023 Dec 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Microbiology%22">American Society for Microbiology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0315061 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-6596 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200664804%22">00664804 </searchLink><i>NLM ISO Abbreviation: </i>Antimicrob Agents Chemother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38047645
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1128/aac.00953-23
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0095323
    Titles:
      – TitleFull: Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Strizki JM
      – PersonEntity:
          Name:
            NameFull: Gaspar JM
      – PersonEntity:
          Name:
            NameFull: Howe JA
      – PersonEntity:
          Name:
            NameFull: Hutchins B
      – PersonEntity:
          Name:
            NameFull: Mohri H
      – PersonEntity:
          Name:
            NameFull: Nair MS
      – PersonEntity:
          Name:
            NameFull: Kinek KC
      – PersonEntity:
          Name:
            NameFull: McKenna P
      – PersonEntity:
          Name:
            NameFull: Goh SL
      – PersonEntity:
          Name:
            NameFull: Murgolo N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 01
              Text: 2024 Jan 10
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1098-6596
          Numbering:
            – Type: volume
              Value: 68
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Antimicrobial agents and chemotherapy
              Type: main
ResultId 1